Independent Family Office’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Hold
2,257
0.45% 39
2026
Q1
$1.11M Hold
2,257
0.46% 39
2025
Q4
$1.31M Hold
2,257
0.55% 30
2025
Q3
$1.09M Hold
2,257
0.46% 40
2025
Q2
$915K Hold
2,257
0.42% 42
2025
Q1
$1.12M Hold
2,257
0.59% 31
2024
Q4
$1.17M Hold
2,257
0.61% 30
2024
Q3
$1.4M Sell
2,257
-896
-28% -$530K 0.7% 26
2024
Q2
$1.74M Hold
3,153
0.99% 19
2024
Q1
$1.83M Hold
3,153
0.98% 23
2023
Q4
$1.67M Hold
3,153
0.95% 22
2023
Q3
$1.6M Hold
3,153
1% 22
2023
Q2
$1.65M Hold
3,153
1% 22
2023
Q1
$1.82M Hold
3,153
1.05% 21
2022
Q4
$1.74M Hold
3,153
1.04% 21
2022
Q3
$1.6M Buy
3,153
+2,257
+252% +$1.26M 0.79% 21
2022
Q2
$487 Sell
896
-1,594
-64% -$877K 0.24% 42
2022
Q1
$1.47M Buy
+2,490
New +$1.43M 0.48% 21

Other funds holding TMO

Independent Family Office's TMO Position: Q2 2026 in Review

Independent Family Office held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 2,257 shares worth $1.13M. The position accounts for 0.45% of the portfolio, ranked #39.

Independent Family Office first reported a position in TMO in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.83M in Q1 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Independent Family Office held 2,257 shares of Thermo Fisher Scientific worth $1.13M as of Q2 2026.
  • Independent Family Office left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.45% of Independent Family Office's portfolio in Q2 2026, its #39 holding.
  • Independent Family Office first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 18 quarters since.
  • Independent Family Office's Thermo Fisher Scientific position peaked at $1.83M in Q1 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Independent Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.